NCT00299637

Brief Summary

This study will try to determine whether fetuses to mothers having clinical chorioamnionitis have changes in blood flow in middle cerebral artery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
34

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2006

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 5, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 7, 2006

Completed
7 months until next milestone

Study Start

First participant enrolled

October 1, 2006

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2007

Completed
Last Updated

November 30, 2006

Status Verified

March 1, 2006

First QC Date

March 5, 2006

Last Update Submit

November 29, 2006

Conditions

Chorioamnionitis

Eligibility Criteria

Age20 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • women giving birth week 37-42
  • healthy
  • one fetus

You may not qualify if:

  • more than one fetus
  • IUGR
  • illness or damage to fetus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Haddasah Medical Organization

Jerusalem, 12000, Israel

RECRUITING

MeSH Terms

Conditions

Chorioamnionitis

Condition Hierarchy (Ancestors)

Fetal DiseasesPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesFetal Membranes, Premature RuptureObstetric Labor ComplicationsPlacenta DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • David Mankuta, MD

    Hadassah Medical Organization

    STUDY CHAIR

Central Study Contacts

david mankuta, MD

CONTACT

mankuta@yahoo.com

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
OTHER
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 5, 2006

First Posted

March 7, 2006

Study Start

October 1, 2006

Study Completion

December 1, 2007

Last Updated

November 30, 2006

Record last verified: 2006-03

Locations

IL(1)